WLD - Looking better for 2017..., page-58

First 58 Last

Share
Profile

Follow
norsc

1,215 Posts.

22

01/09/16

08:38

Post #: 18844914
Share

Originally posted by cheplan ↑

Just listened to Wellard presentation conference at 2pm today.

I won't repeat the financials that have already covered in the presentation reports.

1. Tough market (last 6 to 8 months): High prices due to wet weather and difficulty negotiating higher margins with customers. Normally (for the last 2o years), Wellard has simply added margin on cattle pricing and passed onto customers. Normal margin selling should return to market.

2. Pursuing expansion strategy. That is, market diversification and increased shipping capacity (Shearer and Keplie). The purpose for listing on ASX to was take Wellard to the "next level". Diversification into other markets, particularly South American and China. Increase live cattle "footprint"from/for Wellard. Shipped recorded number of livestock last financial year. Mario expects first delivery to China by year end or 2017.

3. Current status: 1) all vessels busy, 2) management committed to growing Wellard, 3) sourcing and livestock from Australia and South America, and 4) preparing for increased livestock demand internationally.

4. Why has $15m payment from WGH taken so long? The payment in still within agreed terms. There has been no breach. Negotiation is under way with a international bank so that payment will be made on time.

5. Will you (Mario) remain with Wellard? He will. He is selling his Australian assets and moving to Singapore to better manage the business. Why? Mario negotiates most of the larger country by country deals and does so on-site. Perth is too far away to negotiate such deals. Mario is less involved in the operational management of Wellard. He focuses on business expansion directly with countries and customers.

6. Why are the audited accounts delayed until end of September? To allow for renegotiated working capacity facility and financial covenants to be reviewed (30 September and 31 December). Importantly, Wellard is not in default with any debt facility. However, Wellard are currently negotiating with debt providers to waiver anticipated breaches or changes to covenant terms prior to end of September and before presentation of audited accounts.

Expand

Hey Cheplan...where was this Wellard presentation conference at 2pm yesterday?

Do you attend?..or listen via phone / web etc ?

Was it recorded & is it available somewhere?

Thanks

WLD Price at posting: 28.5¢ Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

MXR

Maximus jumps 7% as it unveils latest gold drill hits at Eagles Nest; grades up to 15g/t

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

PCK

PainChek close to finding out if FDA approves its flagship app for use in dementia care

There are more pages in this discussion • 151 more messages in this thread...

First 58 Last

Add WLD (ASX) to my watchlist

(20min delay)
Last 6.6¢		Change 0.000(0.00%)		Mkt cap ! $35.06M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
1	129949	6.3¢

Sellers (Offers)

Price($)	Vol.	No.
6.6¢	1187	1

View Market Depth

No.	Vol.	Price($)
1	129949	0.063
1	227211	0.062
2	111000	0.061
1	75000	0.059
1	9300	0.054

Price($)	Vol.	No.
0.066	1187	1
0.069	53000	2
0.070	80000	1
0.072	26661	1
0.073	20000	1

Last trade - 10.09am 02/10/2024 (20 minute delay)

WLD (ASX) Chart

Day chart unavailable

WLD - Looking better for 2017..., page-58

Maximus jumps 7% as it unveils latest gold drill hits at Eagles Nest; grades up to 15g/t

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

PainChek close to finding out if FDA approves its flagship app for use in dementia care

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

WLD - Looking better for 2017..., page-58

Top Stories

Maximus jumps 7% as it unveils latest gold drill hits at Eagles Nest; grades up to 15g/t

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

PainChek close to finding out if FDA approves its flagship app for use in dementia care

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News